| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/11/2004 | EP1387835A1 A process for lactonization to produce highly pure simvastatin |
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 02/10/2004 | US6689889 Using n-acryloxyphenylaniline neomenthylamide |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689590 Isolating pravastatin, compactin and lovastatin from a fermentation broths; obtain solution, purify salt of statins, recover statins |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2003074475A3 Substituted aryl ketones |
| 02/05/2004 | US20040024228 Such as 5-hydroxy-2,6-norbornanecarbolactone via cyclization of unsaturated carboxylic acids |
| 02/05/2004 | US20040024221 Comprises (2S,5S)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one as catalyst; for synthesis of (2S,3S)-3-hydroxy-2-methylpentanal |
| 02/05/2004 | US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases |
| 02/05/2004 | US20040023958 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/04/2004 | EP1385856A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/03/2004 | US6686481 Highly purified simvastatin compositions |
| 01/29/2004 | WO2004009749A1 Fragrance composition |
| 01/29/2004 | WO2004009574A1 Synthesis of discodermolide |
| 01/29/2004 | WO2004009573A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | WO2004009079A1 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 01/29/2004 | WO2004009067A1 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence |
| 01/29/2004 | WO2003032905A3 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 01/29/2004 | US20040019225 Process for lactonization to produce simvastatin |
| 01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
| 01/29/2004 | US20040018598 Chemical intermediate for discodermolide, epothilone |
| 01/29/2004 | US20040016906 Difluoromethyl ether derivative and process for producing the same |
| 01/29/2004 | DE10233048A1 Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken Use of 1-phenyl-3dimethylamino-propane compounds for the therapy of depressive symptomatology |
| 01/29/2004 | CA2493876A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/28/2004 | EP1383764A1 Ratjadone derivatives for inhibiting cell growth |
| 01/28/2004 | EP0842290B1 Process for the preparation of lovastatin |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1136207C Catalyst for preparing lactone and process for preparing lactone |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/22/2004 | WO2004006865A2 Compounds, compositions, and methods |
| 01/22/2004 | US20040015005 Esterification using hafnium catalyst |
| 01/22/2004 | US20040014992 A dichlorobenzylcyanide or a dichlorophenylcyclohexyl acetic acid methyl ester; use as antagonist of serotonin receptor and dopamine, treating attention deficit hyperactivity disorder, Parkinson's disease, nervous system disorders |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/22/2004 | DE10228183A1 3,3,4,4-Tetrafluorcyclopentanverbindungen 3,3,4,4-tetrafluoroethane cyclopentadiene compounds |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1278738B1 The oxidation of ketones to esters using a tin substituted zeolite beta |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/20/2004 | US6680389 Acrylic esters containing fluorine at alpha-position and having a lactone ring introduced into the ester side chain thereof; useful as monomers to produce base polymers for use in chemically amplified resist compositions |
| 01/20/2004 | US6680338 Matrix metalloproteinase and tumor necrosis factor inhibitors; anticarcinogenic agents; rheumatoid arthritis |
| 01/20/2004 | US6680132 Red organic electroluminescent devices |
| 01/20/2004 | CA2191893C Process for the preparation of heterocyclic aldehydes |
| 01/15/2004 | WO2004005275A1 Fed batch solid state fermentation for the production of hmg-coa reductase inhibitors |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040009999 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
| 01/15/2004 | DE10229530A1 Chirale 3,4-Dihydro-2H-pyranverbindungen Chiral 3,4-dihydro-2H-pyran compounds |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468098A Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
| 01/14/2004 | CN1134426C Method for preparing substituted benzodihydropyran derivative |
| 01/13/2004 | US6677487 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base |
| 01/13/2004 | US6677462 S-(+)-4-methoxy-6-phenethyl-5,6-dihydro-pyran-2-one; plant extracts for nutraceutical foods, topical ointments |
| 01/08/2004 | WO2004002979A2 Chiral 3,4-dihydro-2h-pyran compounds |
| 01/08/2004 | WO2003064378A3 Novel compounds that inhibit factor xa activity |
| 01/08/2004 | US20040006227 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | US20040004207 Difluoromethyl ether derivative and process for producing the same |
| 01/07/2004 | EP1377565A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 01/07/2004 | EP1377373A1 Improved method for producing unsaturated cyclic ethers |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/02/2004 | EP1373548A1 Chemo-enzymatic synthesis of optically enriched rose-oxides |
| 01/02/2004 | EP1373241A1 Method for producing optically active dihydropyrones |
| 01/02/2004 | EP1373195A2 Quaternary amino acids on solid supports |
| 12/31/2003 | WO2004000827A1 Method for producing carbonyl compounds |
| 12/31/2003 | WO2004000825A1 Novel compounds |
| 12/31/2003 | WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | WO2004000783A1 Aminoalkylphenols, methods of using and making the same |
| 12/31/2003 | WO2004000771A1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media |
| 12/31/2003 | CN1132829C Crystalline N-acetyl neuraminic acid derivatives and process for their preparation |
| 12/31/2003 | CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/30/2003 | US6670488 Substituted phenylketoenols |
| 12/30/2003 | US6670385 α-phenyl-βketosulfone |
| 12/25/2003 | US20030236416 Hydroxamic and carboxylic acid derivatives |
| 12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
| 12/25/2003 | US20030236302 Plant extracts; central nervous system disorders |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236200 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 12/25/2003 | US20030236167 Novel herbicides |
| 12/24/2003 | WO2003105769A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 12/24/2003 | WO2003048148A9 Statin-like compounds |
| 12/24/2003 | CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy |
| 12/23/2003 | US6667415 Tertiary butyl 4,4-bis(4′-hydroxyphenyl) pentanoate derivatives and positive resist materials containing the same |
| 12/18/2003 | WO2003104215A1 Process for producing tetrahydropyran-4-ol, intermediate therefor, and process for producing the same |
| 12/18/2003 | WO2003103656A1 O-substituted hydroxyaryl derivatives |
| 12/18/2003 | US20030232880 For therapy of pain, fever or inflammation to inhibit prostanoid-induced smooth muscle contraction; for prophylaxis and therapy of colorectal cancer or neurodegenerative diseases |